Screening for prostate cancer
26 results
1 - 26
Screening for prostate cancer- 5‐alpha‐reductase inhibitors for prostate cancer prevention
- Lycopene for the prevention of prostate cancer
- Bisphosphonates for advanced prostate cancer
- Radical prostatectomy versus deferred treatment for localised prostate cancer
- Screening for testicular cancer
- Primary cryotherapy for localised or locally advanced prostate cancer
- Psychosocial interventions for men with prostate cancer: Cochrane systematic review
- Non‐steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer
- Government regulation of private health insurance
- Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery
- Systematic screening and assessment of psychosocial well‐being and care needs of people with cancer
- Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis
- Decision aids for people facing health treatment or screening decisions
- Personalised risk communication for informed decision making about taking screening tests: Cochrane systematic review
- Interventions for promoting habitual exercise in people living with and beyond cancer
- Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults
- Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer
- Green and black tea for the primary prevention of cardiovascular disease: Cochrane systematic review
- Interventions for managing medication‐related osteonecrosis of the jaw
- Penile rehabilitation for postprostatectomy erectile dysfunction